James Garner
Vermögen: 9 979 $ am 31.05.2026
Vermögen: 9 979 $ am 31.05.2026
James Stuart Garner currently works at Percheron Therapeutics Ltd., as Chief Executive Officer, MD & Director from 2023 and Australian Institute of Co. Directors, as Member.
Dr. Garner also formerly worked at Kazia Therapeutics Ltd., as Chief Executive Officer, MD & Executive Director from 2016 to 2023, TBG Diagnostics Ltd., as Vice President-Clinical & Medical Affairs, and Takeda Pharmaceuticals Australia Pty Ltd., as Vice President-Research & Development from 2009 to 2013.
Dr. Garner received his graduate degree and Masters Business Admin degree from The University of Queensland and undergraduate degree from University College London.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.12.2024 | 3’080’001 ( 0.2% ) | 9 979 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Vorstandsvorsitzender | 07.08.2023 |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Vorstandsvorsitzender | 01.05.2023 |
Takeda Pharmaceuticals Australia Pty Ltd.
Takeda Pharmaceuticals Australia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufactures medicines | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
| TBG DIAGNOSTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 12.11.2008 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Kazia Therapeutics Ltd.
Kazia Therapeutics Ltd. BiotechnologyHealth Technology Engages in the business of pharmaceutical research and development | Health Technology |
Percheron Therapeutics Ltd.
Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
TBG Diagnostics Ltd.
TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule pharmaceuticals for the treatment of cancer | Health Technology |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Takeda Pharmaceuticals Australia Pty Ltd.
Takeda Pharmaceuticals Australia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research, development and manufactures medicines | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen